A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder

Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed to the average age of four years...

Descripción completa

Detalles Bibliográficos
Autores principales: Olesova, Dominika, Galba, Jaroslav, Piestansky, Juraj, Celusakova, Hana, Repiska, Gabriela, Babinska, Katarina, Ostatnikova, Daniela, Katina, Stanislav, Kovac, Andrej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693535/
https://www.ncbi.nlm.nih.gov/pubmed/33147863
http://dx.doi.org/10.3390/metabo10110443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693535/
https://www.ncbi.nlm.nih.gov/pubmed/33147863
http://dx.doi.org/10.3390/metabo10110443

Ejemplares similares